These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 24690311)
1. MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression. Matte I; Lane D; Boivin M; Rancourt C; Piché A BMC Cancer; 2014 Apr; 14():234. PubMed ID: 24690311 [TBL] [Abstract][Full Text] [Related]
2. MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis. Thériault C; Pinard M; Comamala M; Migneault M; Beaudin J; Matte I; Boivin M; Piché A; Rancourt C Gynecol Oncol; 2011 Jun; 121(3):434-43. PubMed ID: 21421261 [TBL] [Abstract][Full Text] [Related]
3. CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis. Boivin M; Lane D; Piché A; Rancourt C Gynecol Oncol; 2009 Dec; 115(3):407-13. PubMed ID: 19747716 [TBL] [Abstract][Full Text] [Related]
4. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis. Geserick P; Drewniok C; Hupe M; Haas TL; Diessenbacher P; Sprick MR; Schön MP; Henkler F; Gollnick H; Walczak H; Leverkus M Oncogene; 2008 May; 27(22):3211-20. PubMed ID: 18084329 [TBL] [Abstract][Full Text] [Related]
5. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429 [TBL] [Abstract][Full Text] [Related]
6. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation. Rosato RR; Almenara JA; Coe S; Grant S Cancer Res; 2007 Oct; 67(19):9490-500. PubMed ID: 17909059 [TBL] [Abstract][Full Text] [Related]
7. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas. Bellail AC; Tse MC; Song JH; Phuphanich S; Olson JJ; Sun SY; Hao C J Cell Mol Med; 2010 Jun; 14(6A):1303-17. PubMed ID: 19432816 [TBL] [Abstract][Full Text] [Related]
8. ER stress sensitizes cells to TRAIL through down-regulation of FLIP and Mcl-1 and PERK-dependent up-regulation of TRAIL-R2. Martín-Pérez R; Niwa M; López-Rivas A Apoptosis; 2012 Apr; 17(4):349-63. PubMed ID: 22072062 [TBL] [Abstract][Full Text] [Related]
9. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837 [TBL] [Abstract][Full Text] [Related]
10. α-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway. Yu W; Tiwary R; Li J; Park SK; Jia L; Xiong A; Simmons-Menchaca M; Sanders BG; Kline K Mol Carcinog; 2010 Nov; 49(11):964-73. PubMed ID: 20886583 [TBL] [Abstract][Full Text] [Related]
11. The SCF Roberts JZ; Holohan C; Sessler T; Fox J; Crawford N; Riley JS; Khawaja H; Majkut J; Evergren E; Humphreys LM; Ferris J; Higgins C; Espona-Fiedler M; Moynagh P; McDade SS; Longley DB Cell Death Differ; 2020 Sep; 27(9):2726-2741. PubMed ID: 32313199 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of cFLIP following reovirus infection sensitizes human ovarian cancer cells to TRAIL-induced apoptosis. Clarke P; Tyler KL Apoptosis; 2007 Jan; 12(1):211-23. PubMed ID: 17136319 [TBL] [Abstract][Full Text] [Related]
13. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L). Guseva NV; Rokhlin OW; Taghiyev AF; Cohen MB Breast Cancer Res Treat; 2008 Feb; 107(3):349-57. PubMed ID: 17453339 [TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of FLICE-like inhibitory protein expression with small interfering RNA oligonucleotides is sufficient to sensitize tumor cells for TRAIL-induced apoptosis. Siegmund D; Hadwiger P; Pfizenmaier K; Vornlocher HP; Wajant H Mol Med; 2002 Nov; 8(11):725-32. PubMed ID: 12520089 [TBL] [Abstract][Full Text] [Related]
15. The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer. Duiker EW; van der Zee AG; de Graeff P; Boersma-van Ek W; Hollema H; de Bock GH; de Jong S; de Vries EG Gynecol Oncol; 2010 Mar; 116(3):549-55. PubMed ID: 19959214 [TBL] [Abstract][Full Text] [Related]
16. Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3. Garg G; Gibbs J; Belt B; Powell MA; Mutch DG; Goedegebuure P; Collins L; Piwnica-Worms D; Hawkins WG; Spitzer D BMC Cancer; 2014 Jan; 14():35. PubMed ID: 24447304 [TBL] [Abstract][Full Text] [Related]
17. Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex. Kavuri SM; Geserick P; Berg D; Dimitrova DP; Feoktistova M; Siegmund D; Gollnick H; Neumann M; Wajant H; Leverkus M J Biol Chem; 2011 May; 286(19):16631-46. PubMed ID: 21454681 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells. Comamala M; Pinard M; Thériault C; Matte I; Albert A; Boivin M; Beaudin J; Piché A; Rancourt C Br J Cancer; 2011 Mar; 104(6):989-99. PubMed ID: 21326240 [TBL] [Abstract][Full Text] [Related]
19. Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells. Zhu ZC; Liu JW; Yang C; Li MJ; Wu RJ; Xiong ZQ Cell Death Dis; 2019 Feb; 10(2):118. PubMed ID: 30742128 [TBL] [Abstract][Full Text] [Related]